crc press - E-Lib FK UWKS

20 Cell-Penetrating Peptides: Processes and Applications
30. Pooga, M. et al., Cell penetrating PNA constructs regulate galanin receptor levels and
modify pain transmission in vivo, Nat. Biotechnol., 16, 857–861, 1998.
31. Wei, Z. et al., Hybridization properties of oligodeoxynucleotide pairs bridged by
polyarginine peptides, Nucleic Acids Res., 24, 655–661, 1996.
32. Dunican, D.J. and Doherty, P., Designing cell-permeant phosphopeptides to modulate
intracellular signaling pathways, Biopolymers, 60, 45–60, 2001.
33. Vivès, E. et al., Structure activity relationship study of the plasma membrane translocating
potential of a short peptide from HIV-1 Tat protein, Lett. Peptide Sci., 4,
429–436, 1997.
34. Lane, D., Awakening angels, Nature, 394, 616–617, 1998.
35. Lu, J. et al., TAP-independent presentation of CTL epitopes by Trojan antigens, J.
Immunol., 166, 7063–7071, 2001.
36. Schwarze, S.R. et al., In vivo protein transduction: delivery of a biologically active
protein into the mouse, Science, 285, 1569–1572, 1999.
37. Ford, K.G. et al., Protein transduction: an alternative to genetic intervention? Gene
Ther., 8, 1–4, 2001.
38. Curiel, D.T. et al., Adenovirus enhancement of transferrin-polylysine-mediated gene
delivery, Proc. Natl. Acad. Sci. USA, 88, 8850–8854, 1991.
39. Eguchi, A. et al., Protein transduction domain of HIV-1 Tat protein promotes efficient
delivery of DNA into mammalian cells, J. Biol. Chem., 276, 26204–26210, 2001.
40. Weissleder, R. et al., In vivo magnetic resonance imaging of transgene expression,
Nat. Med., 6, 351–355, 2000.
41. Lewin, M. et al., Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking
and recovery of progenitor cells, Nat. Biotechnol., 18, 410–414, 2000.
42. Torchilin, V.P. et al., TAT peptide on the surface of liposomes affords their efficient
intracellular delivery even at low temperature and in the presence of metabolic
inhibitors, Proc. Natl. Acad. Sci. USA, 98, 8786–8791, 2001.
43. Mann, D.A. and Frankel, A.D., Endocytosis and targeting of exogenous HIV-1 Tat
protein, Embo. J., 10, 1733–1739, 1991.
44. Tyagi, M. et al., Internalization of HIV-1 tat requires cell surface heparan sulfate
proteoglycans, J. Biol. Chem., 276, 3254–3261, 2001.
45. Liu, Y. et al., Uptake of HIV-1 Tat protein mediated by low-density lipoprotein
receptor-related protein disrupts the neuronal metabolic balance of the receptor
ligands, Nat. Med., 6, 1380–1387, 2000.
46. Barillari, G.R. et al., The Tat protein of human immunodeficiency virus type 1, a
growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces
adhesion of the same cell types by using integrin receptors recognizing the RGD
amino acid sequence, Proc. Natl. Acad. Sci U.S.A., 90, 7941–7945, 1993.
47. Wender, P.A. et al., The design, synthesis, and evaluation of molecules that enable
or enhance cellular uptake: peptoid molecular transporters, Proc. Natl. Acad. Sci.
USA, 97, 13003–13008, 2000.
48. Polyakov, V. et al., Novel Tat-peptide chelates for direct transduction of technetium-
99m and rhenium into human cells for imaging and radiotherapy, Bioconjug. Chem.,
11, 762–771, 2000.
49. Drin, G. et al., Physico-chemical requirements for cellular uptake of pAntp peptide.
Role of lipid-binding affinity, Eur. J. Biochem., 268, 1304–1314, 2001.
50. Pooga, M. et al., Cell penetration by transportan, FASEB J., 12, 67–77, 1998.
51. Futaki, S. et al., Arginine-rich peptides. An abundant source of membrane-permeable
peptides having potential as carriers for intracellular protein delivery, J. Biol. Chem.,
276, 5836–5840, 2001.